ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672215 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672215; 2) Community: the network communities that were significantly associated with the response to NSC 672215; 3) Molecule: the relationships between components within communities and NSC 672215; 4) MDR: the compounds that were significantly associated with the NSC 672215.

NSC Compound Enrichment Correlation
NSC 656209 Null 0.0152777849043087 0.31477062
NSC 657270 (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.0152777849043087 0.085066683
NSC 661415 2-Chloro-3-(2-butoxyethoxy)naphthazarin 0.0152777849043087 0.41988858
NSC 662784 Null 0.0152777849043087 0.41578891
NSC 18805 .gamma.-Thujaplicine 0.0164116791870034 0.34275066
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0164116791870034 0.64769549
NSC 313681 Oxiperomide(USAN) 0.0164116791870034 0.060148857
NSC 328410 Camptothecin Derivative 0.0164116791870034 0.51349798
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0164116791870034 0.12474539
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0164116791870034 0.37341027
Total:128  Current:47    [First] [Prev] [Next] [Last]